Everence Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,090
Closed -$195 764
2024
Q2
$195 Hold
11,090
0.01% 685
2024
Q1
$208 Hold
11,090
0.01% 702
2023
Q4
$251K Buy
+11,090
New +$240K 0.02% 618
2022
Q2
Sell
-12,950
Closed -$281K 717
2022
Q1
$281K Buy
12,950
+5,190
+67% +$113K 0.02% 575
2021
Q4
$215K Buy
+7,760
New +$188K 0.02% 711
2019
Q1
Sell
-13,360
Closed -$98K 626
2018
Q4
$98K Hold
13,360
0.02% 404
2018
Q3
$117K Hold
13,360
0.02% 428
2018
Q2
$150K Hold
13,360
0.03% 417
2018
Q1
$148K Buy
+13,360
New +$167K 0.03% 400

Other funds holding CCRN

Everence Capital Management's CCRN Position: Q3 2024 in Review

Everence Capital Management sold out of Cross Country Healthcare (CCRN) in Q3 2024, closing a stake of 11,090 shares — an estimated $195 sold.

Everence Capital Management first reported a position in CCRN in Q1 2018 and held it in 9 quarters. The position peaked at $281K in Q1 2022. 180 funds tracked by Wall St. Rank hold CCRN as of Q3 2024.

  • Everence Capital Management reported no remaining Cross Country Healthcare position as of Q3 2024 after selling out during the quarter.
  • Everence Capital Management sold 11,090 Cross Country Healthcare shares in Q3 2024, an estimated $195.
  • Everence Capital Management first reported a position in Cross Country Healthcare in Q1 2018 and held it in 9 quarters.
  • Everence Capital Management's Cross Country Healthcare position peaked at $281K in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2024.

Based on Everence Capital Management's 13F filing for Q3 2024, filed 21 Oct 2024.